Effects of Coenzyme Q10 on the Heart Ultrastructure and Nitric Oxide Synthase during Hyperthyroidism

Fusun Oztay；Bulent Ergin；Savas Ustunova；Huriye Balci；Aysegul Kapucu；Metin Caner；Cihan Demirci

hyperthyroid heart ； nitric oxide synthase ； ultrastructure ； CoQ10 ； mice

The Chinese Journal of Physiology

50卷5期（2007 / 10 / 31）

217 - 224

英文

Coenzyme Q10 is an important component of mitochondrial electron transport chain and antioxidant. Hyperthyroidism manifests hyperdynamic circulation with increased cardiac output, increased heart rate and decreased peripheral resistance. The heart is also under the oxidative stress in the hyperthyroidism. The aim of this study was to examine both how the coenzyme Q10 can affect heart ultrastructure in the hyperthyroidism and how the relationship between nitric oxide synthase (NOS) and heart damage and coenzyme Q10. Swiss Black C57 mice received 5 mg/kg L-thyroxine. Coenzyme Q10 (1.5mg/kg) and L-thyroxine together was given to second group mice. Coenzyme Q10 and serum physiologic were applied to another two groups, respectively. All treatments were performed daily for 15 days by gavage. Free triiodothyronine and thyroxine were increased in two groups given Lthyroxine; thyroid-stimulating hormone level did not change. Hyperthyroid heart showed an increased endothelial NOS (eNOS) and inducible NOS (iNOS) immunoreactivity in the tissue. Coenzyme Q10 administration decreased these NOS immunoreactivities in the hyperthyroid animals. Cardiomyocytes of the hyperthyroid animals was characterized by abnormal shape and invaginated nuclei, and degenerative giant mitochondria. Desmosome plaques reduced in density. In hyperthyroid mice given coenzyme Q10, the structural disorganization and mitochondrial damage regressed. However, hearts of healthy mice given coenzyme Q10 displayed normal ultrastructure, except for increased mitochondria and some of them were partially damaged. Coenzyme Q10 increased the glycogen in the cardiomyocytes. In conclusion, coenzyme Q10 administration can prevent the ultrastructural disorganization and decrease the iNOS and eNOS increment in the hyperthyroid heart.

1. Balligand, J.L.,Cannon, P.J.(1997).Nitric oxide synthases and cardiac muscle. Autocrine and paracrine influences.Arterioscler. Thromb. Vasc. Biol.,17,1846-1858.
2. Bianchi, G.,Solaroli, E.,Zaccheroni, V.,Grossi, G.,Bargossi, A.M.,Melchionda, N.,Marchesini, G.(1999).Oxidative stress and antioxidant metabolites in patients with hyperthyroidism: effect of treatment.Horm. Metab. Res.,31,620-624.
3. Bolli, R.(2001).Cardioprotective function of inducible nitric oxide synthase and role of nitric oxide in myocardial ischemia and preconditioning: an overview of a decade of research.J. Mol. Cell. Cardiol.,33,1897-1918.
4. Bradley, S.E.,Stephan, F.,Coelho, J.B.,Reville, P.(1974).The thyroid and the kidney.Kidney Int.,6,346-365.
5. Crestanello, J.A.,Doliba, N.M.,Doliba, N.M.,Babsky, A.M.,Niborii, K.,Osbakken, M.D.,Whitman, G.J.R.(2002).Effect of coenzyme Q10 supplementation on mitochondrial function after myocardial ischemia reperfusion.J. Surg. Res.,102,221-228.
6. Ferrara, N.,Abete, P.,Ambrosio, G.,Landino, P.,Caccese, P.,Cirillo, P.,Oradei, A.,Littarru, G.P.,Chiariello, M.,Rengo, F.(1995).Protective role of chronic ubiquinone administration on acute cardiac oxidative stress.J. Pharmacol. Exp. Ther.,274,858-865.
7. Ferreira, P.J.,L`Abbate, C.,Abrahamsohn, P.A.,Gouveia, C.A.,Moriscot, A. S.(2003).Temporal and topographic ultrastructural alterations of rat heart myofibrils caused by thyroid hormone.Microsc. Res. Tech.,62,451-459.
8. Gredilla, R.,Barja, G.,Lopez-Torres, M.(2001).Thyroid hormoneinduced oxidative damage on lipids, glutathione and DNA in mouse heart.Free Radic. Res.,35,417-425.
9. Hu, L.W.,Liberti, E.A.,Barreto-Chaves, M.L.(2005).Myocardial ultrastructure in cardiac hypertrophy induced by thyroid hormonean acute study in rats.Virchows. Arch.,446,265-269.
10. James, A.M.,Cocheme, H.M.,Smith, R.A.,Murphy, M.P.(2005).Interactions of mitochondria-targeted and untargeted ubiquinones with the mitochondrial respiratory chain and reactive oxygen species. Implications for the use of exogenous ubiquinones as therapies and experimental tools.J. Biol. Chem.,280,21295-21312.
11. Kelly, R.A.,Balligand, J.L.,Smith, T.W.(1996).Nitric oxide and cardiac function..Circ. Res.,79,363-380.
12. Klein, I.(1990).Thyroid hormone and the cardiovascular system.Am. J. Med.,88,631-637.
13. Klein, I.,Ojamaa, K.,Laragh JH,Brenner BN (edited)(1995).Thyroid hormone and blood pressure regulation. In: Hypertension: Pathophysiology, diagnosis and Management.New York:Raven Press.
14. Kwong, L.K.,Kamzalov, S.,Rebrin, I.,Bayne, A.C.,Lana, C.K.,Morris, P.,Forster, M.J.,Sohal, R.S.(2002).Effects of coenzyme Q (10) administration on its tissue concentrations, mitochondrial oxidant generation, and oxidative stress in the rat.Free Radic. Biol. Med.,33,627-638.
15. Lakomkin, V.L.,Konovalo, G.G.,Kalenikova, E.I.,Zabbarova, I.V.,Tikhaze, A.K.,Tsyplenkova, V.G.,Lankin, V.Z.,Ruuge, E.K.,Kapelko, V.I.(2004).Protection of rat myocardium by coenzyme Q during oxidative stress induced by hydrogen peroxide.Biochemistry (Mosc),69,520-526.
16. Lakomkin, V.L.,Konovalova, G.G.,Kalenikova, E.I.,Zabbarova, I.V.,Kaminnyi, A.I.,Tikhaze, A.K.,Lankin, V.Z.,Ruuge, E.K.,Kapelko, V.I.(2005).Changes in antioxidant status of myocardium during oxidative stress under the influence of coenzyme Q10.Biochemistry (Mosc),70,79-84.
17. Legato, M.J.,Mulieri, L.A.,Alpert, N.R.(1984).The ultrastructure of myocardial hypertrophy: why does the compensated heart fail?.Eur. Heart J.,5,251-269.
18. Liu, Y.H.,Carretero, O.A,Cingolani, O.H.,Liao, T.D.,Sun, Y.,Xu, J.,Li, L.Y.,Pagano, P.J.,Yang, J.J.,Yang, X.P.(2005).Role of inducible nitric oxide synthase in cardiac function and remodeling in mice with heart failure due to myocardial infarction..Am. J. Physiol. Heart Circ. Physiol.,289,2616-2623.
19. Loke, K.E.,McConnell, P.I.,Tuzman, J.M.,Shesely, E.G.,Smith, C.J.,Stackpole, C.J.,Thompson, C.I.,Kaley, G.,Wolin, M.S.,Hintze, T.H.(1999).Endogenous endothelial nitric oxide synthase-derived nitric oxide is a physiological regulator of myocardial oxygen consumption.Circ. Res.,84,840-845.
20. Mano, T.,Sinohara, R.,Sawai, Y.,Oda, N.,Nishida, Y.,Mokuno, T.,Kotake, M.,Hamada, M.,Masunaga, R.,Nakai, A.(1995).Effects of thyroid hormone on coenzyme Q and other free radical scavengers in rat heart muscle.J. Endocrinol.,145,131-136.
21. Masullo, P.,Venditti, P.,Agnisolo, C.,Di Meo, S.(2000).Role of nitric oxide in the reperfusion induced injury in hyperthyroid rat hearts.Free Radic. Res.,32,411-421.
22. Mungrue, I.N.,Husain, M.,Stewart, D.J.(2002).The role of NOS in heart failure: Lessons from murine genetic models..Heart Fail. Rev.,7,407-422.
23. Pandolfi, C.,Ferrari, D.,Stanic, I.,Pellegrini, L.(1994).Circulating levels of CoQ10 in hypo- and hyperthyroidism.Minerva. Endocrinol,19,139-142.
24. Paukov, V.S.,Abinder, A.A.,Khitrov, N.K.(1975).The dynamics of thyrotoxic heart development in experimental thyrotoxicosis.Arkh. Patol.,37,59-67.
25. Paulus, W.J.,Bronzwaer, J.G.F.(2002).Myocardial contractile effects of nitric oxide.Heart Fail. Rev.,7,371-383.
26. Rodriquez-Gomez, I.,Sainz, J.,Wangensteen, R.,Moreno, J.M.,Duarte, J.,Osuna, A.,Vargas, F.(2003).Increased pressor sensitivity to chronic nitric oxide deficiency in hyperthyroid rats.Hypertension,42,220-225.
27. Schopfer, F.,Riobo, N.,Carreras, M.C.,Alvarez, B.,Radi, R.,Boveris, A.,Cadenas, E.,Poderoso, J.J.(2000).Oxidation of ubiquinol by peroxynitrite: implications for protection of mitochondria against nitrosative damage.Biochem. J.,349,35-42.
28. Shen, W.,Xu, X.,Ochoa, M.,Zhao, G.,Wolin, M.S.,Hintze, T.H.(1994).Role of nitric oxide in the regulation of oxygen consumption in conscious dogs.Circ. Res.,75,1086-1095.
29. Shimojo, N.,Jesmin, S.,Zaedi, S.,Somo, M.,Kobayashi, T.,Maeda, S.,Yamaguchi, I.,Goto, K.,Miyauchi, T.(2006).EPA effect on NOS gene expression and on NO level in endothelin-1 induced hyperthyroid cardiomyocytes.Exp. Biol. Med. (Maywood),231,913-918.
30. Sun, Y.,Carretero, O.A.,Xu, J.,Raleb, N.E.,Wang, F.,Lin, C.,Yang, J.J.,Pagano, P.J.,Yang, X.P.(2005).Lack of inducible NO synthase reduces oxidative stress and enhances cardiac response to isoproterenol in mice with deoxycorticosterone acetate salt hypertension.Hypertension,46,1355-1361.
31. Suzuki, H.,Naitoh, T.,Kuniyoshi Si Banba, N.,Kuroda, H.,Suzuki, Y.,Hiraiwa, M.,Yamazaki, N.,Ishikawa, M.,Hashigami, Y.(1984).Cardiac performance and coenzyme Q10 in thyroid disorders..Endocrinol. Jpn.,31,755-761.
32. Venditti, P.,De Rosa, R.,Cigliano, L.,Agnisola, C.,Di Meo, S.(2004).Role of nitric oxide in the functional response to ischemiareperfusion of heart mitochondria from hyperthyroid rats.Cell. Mol. Life Sci.,61,2244-2252.
33. Venditti, P.,De Rosa, R.,Di Meo, S.(2003).Effect of thyroid state on susceptibility to oxidants and swelling of mitochondria from rat tissues.Free Radic. Biol. Med.,35,485-494.
34. Wajdowicz, A.,Dabros, W.,Zaczek, M.(1996).Myocardial damage in thyrotoxicosis-ultrastructural studies.Pol. J. Pathol.,47,127-133.
35. Wollert, K.C.,Drexler, H.(2002).Regulation of cardiac remodeling by nitric oxide. Focus on cardiac myocyte hypertrophy and apoptosis.Heart Fail. Rev.,7,317-325.